R
ReNeuron Group PLC
LSE:RENE
ReNeuron Group PLC
LSE:RENE
Price:
3.375 GBX
-2.17%
Market Closed
Updated:
May 9, 2024
ReNeuron Group PLC
Cash from Investing Activities
|
ReNeuron Group PLC
Cash from Investing Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
R
|
ReNeuron Group PLC
LSE:RENE
|
Cash from Investing Activities
£5.1m
|
CAGR 3-Years
272%
|
CAGR 5-Years
164%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Investing Activities
-$127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Investing Activities
-$11m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Investing Activities
-$2.9m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Investing Activities
-£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Investing Activities
-£21.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
See Also
What is ReNeuron Group PLC's Cash from Investing Activities?
Cash from Investing Activities
5.1m
GBP
5.1m
GBP
Based on the financial report for Sep 30, 2023, ReNeuron Group PLC's Cash from Investing Activities amounts to 5.1m GBP.
What is ReNeuron Group PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
164%
164%
Over the last year, the Cash from Investing Activities growth was 120%. The average annual Cash from Investing Activities growth rates for ReNeuron Group PLC have been 272% over the past three years , 164% over the past five years .
You don't have any saved screeners yet
